Literature DB >> 17342160

Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes.

S Bidel1, K Silventoinen, G Hu, D-H Lee, J Kaprio, J Tuomilehto.   

Abstract

OBJECTIVES: To study the joint association of coffee consumption and serum gamma-glutamyltransferase (GGT) levels on the risk of developing type II diabetes. DESIGN, SETTING AND
SUBJECTS: A total of 21,826 Finnish men and women who were 35-74 years of age and without any history of diabetes at baseline (years 1982, 1987, 1992 and 1997) were included in the present analyses. They were prospectively followed up for onset of type II diabetes (n=862 cases), death or until the end of the year 2002. Coffee consumption, serum GGT and other study parameters were determined at baseline using standardized measurements. Analyses were stratified by the serum GGT level classified into two classes using the 75th sex-specific percentiles as the cut point.
RESULTS: Coffee consumption was significantly and inversely associated with incident diabetes among both men and women. Serum GGT modified the association between coffee consumption and incident diabetes. Subjects in the high category of coffee consumption with the GGT level > or = 75th percentile showed a significant inverse association for women, and for both sexes combined. The association was not significant in subjects with the GGT level < or = 75th percentile. There was a significant interaction effect of GGT and coffee consumption on risk of type II diabetes in data of women (P=0.05) and in both sexes combined (P=0.02).
CONCLUSIONS: Habitual coffee consumption is associated with lower incidence of type II diabetes particularly in those with higher baseline serum GGT levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17342160     DOI: 10.1038/sj.ejcn.1602712

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  8 in total

Review 1.  [Coffee and diabetes].

Authors:  Kerstin Kempf; Stephan Martin
Journal:  Med Klin (Munich)       Date:  2011-01-16

2.  The relationship of management modality in Saudi patients with type 2 diabetes to components of metabolic syndrome, γ glutamyl transferase and highly sensitive C-reactive protein.

Authors:  Suhad M Bahijri; Maimoona Ahmed; Khalid Al-Shali; Samia Bokhari; Amani Alhozali; Anwar Borai; Amani Gusti; Ghada Ajabnoor; Ahmed Alghamdi; Mohammed Asiri; Jaakko Tuomilehto
Journal:  Ther Adv Chronic Dis       Date:  2016-07-15       Impact factor: 5.091

Review 3.  Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies.

Authors:  Xiubo Jiang; Dongfeng Zhang; Wenjie Jiang
Journal:  Eur J Nutr       Date:  2013-10-23       Impact factor: 5.614

4.  Coffee intake and risk of type 2 diabetes: the Multiethnic Cohort.

Authors:  Taisha Doo; Yukiko Morimoto; Astrid Steinbrecher; Laurence N Kolonel; Gertraud Maskarinec
Journal:  Public Health Nutr       Date:  2013-02-27       Impact factor: 4.022

5.  Smoking and γ-glutamyltransferase: opposite interactions with alcohol consumption and body mass index.

Authors:  Lutz P Breitling; Volker Arndt; Christoph Drath; Dietrich Rothenbacher; Hermann Brenner
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

Review 6.  Endobiogeny: a global approach to systems biology (part 1 of 2).

Authors:  Jean-Claude Lapraz; Kamyar M Hedayat
Journal:  Glob Adv Health Med       Date:  2013-01

Review 7.  Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis.

Authors:  Ming Ding; Shilpa N Bhupathiraju; Mu Chen; Rob M van Dam; Frank B Hu
Journal:  Diabetes Care       Date:  2014-02       Impact factor: 19.112

8.  No effect modification of serum bilirubin or coffee consumption on the association of gamma-glutamyltransferase with glycated hemoglobin in a cross-sectional study of Japanese men and women.

Authors:  Zhenjie Wang; Christopher McMonagle; Shinichiro Yoshimitsu; Sanjeev Budhathoki; Makiko Morita; Kengo Toyomura; Keizo Ohnaka; Ryoichi Takayanagi; Suminori Kono
Journal:  BMC Endocr Disord       Date:  2012-10-23       Impact factor: 2.763

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.